TCM
LUNG icon

TimesSquare Capital Management’s Pulmonx LUNG Stock Holding History

TimesSquare Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,223,754
Closed -$20.4M – 187
2022
Q3 		$20.4M Buy
1,223,754
+9,550
+0.8% +$176K 0.28% 139
2022
Q2 		$17.9M Buy
1,214,204
+140,300
+13% +$2.89M 0.25% 145
2022
Q1 		$26.6M Sell
1,073,904
-181,196
-14% -$4.68M 0.3% 131
2021
Q4 		$40.3M Sell
1,255,100
-17,730
-1% -$648K 0.36% 121
2021
Q3 		$45.8M Buy
1,272,830
+621,720
+95% +$24.5M 0.4% 106
2021
Q2 		$28.7M Buy
651,110
+299,110
+85% +$13M 0.24% 157
2021
Q1 		$16.1M Buy
352,000
+30,600
+10% +$1.76M 0.14% 185
2020
Q4 		$22.2M Buy
+321,400
New +$15.7M 0.18% 172

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return